Richard M. Kostrzewa focuses on Endocrinology, Internal medicine, Agonist, Dopamine and Receptor. His Endocrinology study incorporates themes from Receptor antagonist and Serotonin. His Agonist research integrates issues from Hydroxydopamine, Dopamine receptor D2 and Desipramine.
Richard M. Kostrzewa combines subjects such as Pharmacology and Attention deficit hyperactivity disorder with his study of Dopamine. His Receptor research is multidisciplinary, incorporating perspectives in Antidepressant and Locus coeruleus. His studies in Quinpirole integrate themes in fields like Sensitization and Dopamine receptor D3.
Richard M. Kostrzewa mostly deals with Internal medicine, Endocrinology, Dopamine, Neuroscience and Agonist. 5,7-Dihydroxytryptamine is closely connected to Desipramine in his research, which is encompassed under the umbrella topic of Internal medicine. His work in Endocrinology addresses issues such as Receptor, which are connected to fields such as Central nervous system.
His Dopamine research incorporates themes from Parkinson's disease, Pharmacology and Neurotransmitter. The Neuroscience study combines topics in areas such as Neurotoxicity, Schizophrenia and Neurotoxin. His work carried out in the field of Agonist brings together such families of science as Lesion, Antagonist and 5-HT receptor.
Neuroscience, Internal medicine, Endocrinology, Dopaminergic and Dopamine are his primary areas of study. His Neuroscience research incorporates elements of NMDA receptor, Neurotoxicity, Neurotoxin and Neurodegeneration. His biological study spans a wide range of topics, including Biochemistry and Oncology.
His work carried out in the field of Endocrinology brings together such families of science as Glutamate receptor, Monoamine neurotransmitter and Caspase 3. The various areas that Richard M. Kostrzewa examines in his Dopaminergic study include Agonist, Dopamine receptor and Tardive dyskinesia. The concepts of his Dopamine study are interwoven with issues in Weaning, Parkinson's disease and Desipramine.
His primary scientific interests are in Neuroscience, Internal medicine, Endocrinology, Neurotoxicity and Neurodegeneration. He works on Neuroscience which deals in particular with Dopaminergic. When carried out as part of a general Internal medicine research project, his work on Glutamate receptor, Striatum and Agonist is frequently linked to work in RGS9, therefore connecting diverse disciplines of study.
His Endocrinology research is multidisciplinary, incorporating perspectives in Olanzapine and Sensitization. His Neurotoxicity research integrates issues from Pharmacology toxicology, Pharmacology and Amyotrophic lateral sclerosis, Parkinsonism dementia. His work deals with themes such as Neurocognitive, Neurology, Neurochemistry and Exercise physiology, which intersect with Neurodegeneration.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pharmacological Actions of 6-Hydroxydopamine
Richard M. Kostrzewa;David M. Jacobowitz.
Pharmacological Reviews (1974)
Dopamine receptor supersensitivity
Richard M. Kostrzewa.
Neuroscience & Biobehavioral Reviews (1995)
Necrostatin‐1 protects against glutamate‐induced glutathione depletion and caspase‐independent cell death in HT‐22 cells
Xingshun Xu;Chu C. Chua;Jiming Kong;Richard M. Kostrzewa.
Journal of Neurochemistry (2007)
Physical Exercise Alleviates ADHD Symptoms: Regional Deficits and Development Trajectory
Trevor Archer;Richard M. Kostrzewa.
Neurotoxicity Research (2012)
Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.
Li Gong;R. M. Kostrzewa;R. W. Fuller;K. W. Perry.
Journal of Pharmacology and Experimental Therapeutics (1992)
Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA.
Richard M. Kostrzewa;Li Gong.
Pharmacology, Biochemistry and Behavior (1991)
Neurotoxins and neurotoxic species implicated in neurodegeneration.
Juan Segura-Aguilar;Richard M. Kostrzewa.
Neurotoxicity Research (2004)
Serotonin Neural Adaptations to Ontogenetic Loss of Dopamine Neurons in Rat Brain
Richard M. Kostrzewa;Tomás A. Reader;Laurent Descarries.
Journal of Neurochemistry (2002)
Proposed animal model of attention deficit hyperactivity disorder
Richard M. Kostrzewa;Ryszard Brus;John H. Kalbfleisch;Ken W. Perry.
Brain Research Bulletin (1994)
Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.
Michelle J. Chandley;Attila Szebeni;Katalin Szebeni;Jessica D. Crawford.
The International Journal of Neuropsychopharmacology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: